.
BioEnterprise

Abeona Therapeutics Announces European Regulatory Approval for Phase ½ Gene Therapy Clinical Study for MPS IIA

Abeona Therapeutics announces European regulatory approval for a Phase 1/2 Gene Therapy Clinical Trial utilizing ABO-102 for patients with Sanfilippo syndrome type A. Abeona is conducting the Phase 1/2 clinical study at Cruces University Hospital in Bilbao, Spain.

Read More  >